Ignite Creation Date:
2024-05-05 @ 11:10 PM
Last Modification Date:
2024-10-26 @ 10:29 AM
Study NCT ID:
NCT01264640
Status:
UNKNOWN
Last Update Posted:
2010-12-22
First Post:
2010-12-21
Brief Title:
Anti-Platelet Drugs and Brain-derived Neurotrophic Factor BDNF in Human Serum and Plasma
Sponsor:
University of Rostock
Organization:
University of Rostock
Study Overview
Official Title:
The Impact of Aspirin and Clopidogrel on Brain-derived Neurotrophic Factor BDNF Concentrations in Human Serum and Plasma
Status:
UNKNOWN
Status Verified Date:
2010-07
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The impact of anti-platelet drugs on the concentrations of Brain-derived neurotrophic factor BDNF in human plasma and serum is unknown It is the aim of this study to investigate the impact of a single dose of Aspirin 500 mg or Clopdigrel 600 mg on the concentrations of Brain-derived neurotrophic factor BDNF in plasma and serum of healthy volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None